UnitedHealth Group (UNH) October 600 straddle priced into quarter results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St futures rise on Mideast deal optimism; SpaceX debut in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil falls to near two-month lows as Trump calls off threatened strikes on Iran
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
UnitedHealth Group (UNH) PT Lowered to $595 at RBC Capital
October 16, 2024 6:51 AM EDTRBC Capital analyst Ben Hendrix lowered the price target on UnitedHealth Group (NYSE: UNH) to $595.00 (from $615.00) while maintaining a Outperform rating.
The analyst comments "We raise our 2025 MCR estimate by 70 bps and lower our adjusted EPS estimate to $29.75, which should approximate the... More
UnitedHealth Group (UNH) PT Lowered to $625 at Truist Securities
October 16, 2024 6:36 AM EDTTruist Securities analyst David MacDonald lowered the price target on UnitedHealth Group (NYSE: UNH) to $625.00 (from $640.00) while maintaining a Buy rating.
The analyst comments "While UNH reported mixed 3Q results marked by a higher MLR, tightened 2024 guidance and provided a more conservative first glance at... More
UnitedHealth Group (UNH) PT Lowered to $595 at Deutsche Bank
October 16, 2024 6:17 AM EDTDeutsche Bank analyst George Hill lowered the price target on UnitedHealth Group (NYSE: UNH) to $595.00 (from $632.00) while maintaining a Buy rating.
The analyst comments "Initial 2025 Outlook Comes Up Light: UNH reported F3Q results where the company first commented on its 2025 EPS outlook, with the initial guidance of ~ $30 in EPS being ~4% below the Streets ~$31.25 and the ~8% growth... More
